Da Zeng
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Correction: Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.
Journal: Acta pharmacologica Sinica
Published: May 17, 2026
Multi-Omics Analysis of the Therapeutic Value of MAL2 Based on Data Mining in Human Cancers.
Journal: Frontiers in cell and developmental biology
Published: July 05, 2021
The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer.
Journal: Frontiers in genetics
Published: April 10, 2021
Lipopolysaccharide Affects the Proliferation and Glucose Metabolism of Cervical Cancer Cells Through the FRA1/MDM2/p53 Pathway.
Journal: International journal of medical sciences
Published: April 23, 2020
Hysteroscopic treatment of cesarean scar defect.
Journal: Archives of gynecology and obstetrics
Published: March 17, 2020
Bcl‑2 family: Novel insight into individualized therapy for ovarian cancer (Review).
Journal: International journal of molecular medicine
Published: March 10, 2020
Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.
Journal: Acta pharmacologica Sinica
Published: February 13, 2020
lncRNA ABHD11-AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2.
Journal: Cancer medicine
Published: June 20, 2019
M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Journal: Cancer biology & therapy
Published: May 08, 2019
Expression and function of FRA1 protein in tumors.
Journal: Molecular biology reports
Published: May 02, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026